Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328717 · ClinicalTrials.gov registry record · NA
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01328717: Completed NA study, sponsored by Ascensia Diabetes Care.
NCT01328717 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01328717, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Subjects with diabetes and study staff used an investigational blood glucose monitoring system.
Primary Outcome
Subjects with diabetes and study staff tested subject fingerstick blood using an investigational blood glucose meter (BGM). BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 20% (for reference BG results \>=75mg/dL) and within +/- 15mg/dL(for reference BG results \<75mg/dL) of the reference method results.
Interventions
- DEVICE Contour Link Investigational Blood Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-12 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT01328717 record still lists
NCT01328717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Contour Link Investigational Blood Glucose Monitoring System is the first listed.
NCT01328717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01328717 about?
NCT01328717 is a clinical study titled "Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial". Subjects with diabetes and study staff used an investigational blood glucose monitoring system.
What is the current status of trial NCT01328717?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2010-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01328717?
The interventions under investigation include: Contour Link Investigational Blood Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01328717?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01328717's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia